- Home
- PIPR vs ARWR Comparison
PIPR vs ARWR Comparison
Compare PIPR & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIPR
- ARWR
- Stock Information
- Founded
- PIPR 1895
- ARWR 2003
- Country
- PIPR United States
- ARWR United States
- Employees
- PIPR N/A
- ARWR N/A
- Industry
- PIPR Investment Bankers/Brokers/Service
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PIPR Finance
- ARWR Health Care
- Exchange
- PIPR Nasdaq
- ARWR Nasdaq
- Market Cap
- PIPR 6.2B
- ARWR 5.1B
- IPO Year
- PIPR N/A
- ARWR 1993
- Fundamental
- Price
- PIPR $326.36
- ARWR $40.29
- Analyst Decision
- PIPR Hold
- ARWR Strong Buy
- Analyst Count
- PIPR 3
- ARWR 8
- Target Price
- PIPR $312.50
- ARWR $47.75
- AVG Volume (30 Days)
- PIPR 178.8K
- ARWR 1.8M
- Earning Date
- PIPR 10-31-2025
- ARWR 11-25-2025
- Dividend Yield
- PIPR 1.68%
- ARWR N/A
- EPS Growth
- PIPR 55.41
- ARWR N/A
- EPS
- PIPR 11.86
- ARWR N/A
- Revenue
- PIPR $1,597,729,000.00
- ARWR $572,976,000.00
- Revenue This Year
- PIPR $14.03
- ARWR $21,287.22
- Revenue Next Year
- PIPR $14.02
- ARWR N/A
- P/E Ratio
- PIPR $29.17
- ARWR N/A
- Revenue Growth
- PIPR 10.68
- ARWR 2816.20
- 52 Week Low
- PIPR $202.91
- ARWR $9.57
- 52 Week High
- PIPR $374.77
- ARWR $40.48
- Technical
- Relative Strength Index (RSI)
- PIPR 53.80
- ARWR 65.60
- Support Level
- PIPR $329.10
- ARWR $36.73
- Resistance Level
- PIPR $357.58
- ARWR $40.48
- Average True Range (ATR)
- PIPR 10.36
- ARWR 1.70
- MACD
- PIPR 1.24
- ARWR -0.20
- Stochastic Oscillator
- PIPR 66.80
- ARWR 78.79
About PIPR Piper Sandler Companies
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.